Top Markets
Coin of the day
WayPoint Biomedical Holdings, Inc. WayPoint Biomedical Holdings, Inc.

WayPoint Biomedical Holdings, Inc.

WYPH
Rank in Stocks #41070
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary,... WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
Share Price
$0.0014
Last synced: 2026-08-11
Market Cap
$46.54K
Change (1 day)
0.00%
Change (1 year)
1,300.00%
Country
US
Trade WayPoint Biomedical Holdings, Inc. (WYPH)

Category

Stock price history for WayPoint Biomedical Holdings, Inc. (WYPH)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $0.00 on 2015-04-01
Stock price history of WayPoint Biomedical Holdings, Inc. from 2015 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 236.36%
2024 -50.00%
2023 -99.05%
2022 -78.33%
2021 409.68%
2020 2,254.43%
2019 711.43%
2018 -86.95%
2017 666.00%
2016 233.33%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$204.76 -9.04%
US
$104.57 -39.35%
CA
$29.20 -38.73%
US
$13.84 -8.85%
AU
$86.01 -27.13%
US